RLAY·75943R102·US·equity·Healthcare - Biotechnology-13D/G
RLAY (RELAY THERAPEUTICS INC) is held by 127 institutional investors as of Q1 2026. Largest holders: SB INVESTMENT ADVISERS (UK) LTD ($277.7M), BlackRock, Inc. ($129.1M), STATE STREET CORP ($62M). Net institutional sentiment: Bullish.
See how RLAY's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer